- Ongoing, recruitingTherapeutic exploratory (Phase II)
A phase II, randomized, double-blind, multi-centre trial to evaluate the safety and immunogenicity of BIMERVAX® when coadministered with seasonal surface antigen, inactivated, adjuvanted influenza vaccine (SIIV) in adults older than 65 years of age fully vaccinated against COVID-19.
This study is testing a new COVID-19 vaccine, BIMERVAX®, when given at the same time as a regular flu jab. We want to see if it's safe and how well it helps your body fight off viruses in people over 65.
For: SARS-CoV-2 and InfluenzaSpain - Ongoing, recruitingTherapeutic use (Phase IV)
Optimizing the time of day of influenza vaccine administration in adults aged 60-85 years: A randomized controlled trial
This study is looking at the best time of day for people aged 60-85 to have their flu jab. We want to see if getting the vaccine at a certain time helps your body create more protection against the flu virus.
For: InfluenzaNetherlands - Ongoing, recruitingTherapeutic use (Phase IV)
Immune responses to influenza vaccinations and viruses among health care personnel
This study looks at how well healthcare workers' bodies respond to flu vaccines and flu viruses. Researchers want to understand their immune system's protection against flu, both from past vaccines and current viruses circulating around.
For: Influenza · Immunity against influenzaFinland - Ongoing, recruitingTherapeutic exploratory (Phase II)
CONCOMITANT ADMINISTRATION OF LICENSED VACCINES AGAINST COVID-19 AND FLU WITH OR WITHOUT MF59 ADJUVANT: A MULTI-CENTRE, RANDOMIZED, SINGLE-BLIND CLINICAL TRIAL TO ASSESS IMMUNOGENICITY IN ADULTS AGED 65 AND OVER
This study looks at giving COVID-19 and flu vaccines at the same time to people aged 65 and over. We want to see how well their bodies respond to both vaccines and if it's safe to have them together. This could make it easier for older adults to stay protected.
For: COVID-19 and fluBelgium · Netherlands - Ongoing, recruitingTherapeutic use (Phase IV)
Phase IV multicenter immunogenicity and safety study of the Seqirus licensed zoonotic influenza vaccine (H5N8) in adults immunized with an H5N1/MF59 influenza vaccine, approximately 20 years before the trial, compared to H5 naive adult participants.
This study is looking at a new bird flu vaccine (H5N8) in adults. We want to see how well it helps your body fight off the virus, especially if you had a similar bird flu vaccine (H5N1) many years ago, compared to those who haven't had a bird flu vaccine before.
For: Avian InfluenzaItaly · Belgium - Ongoing, recruitingTherapeutic use (Phase IV)
Impact of influenza vaccination on nasal resident memory immune responses and respiratory peripheral memory immune responses - MUCOVAC 2
This study, MUCOVAC 2, is looking at how flu vaccines protect against the flu. Specifically, it's exploring how the vaccine affects the body's immune cells in the nose and blood, aiming to understand better how our bodies learn to fight off the flu.
For: Adults seeking active immunisation against the seasonal influenza virusFrance